These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


349 related items for PubMed ID: 29992269

  • 1. APOL1 risk genotype in European steroid-resistant nephrotic syndrome and/or focal segmental glomerulosclerosis patients of different African ancestries.
    Gribouval O, Boyer O, Knebelmann B, Karras A, Dantal J, Fourrage C, Alibeu O, Hogan J, Dossier C, Tête MJ, Antignac C, Servais A.
    Nephrol Dial Transplant; 2019 Nov 01; 34(11):1885-1893. PubMed ID: 29992269
    [Abstract] [Full Text] [Related]

  • 2. The podocin V260E mutation predicts steroid resistant nephrotic syndrome in black South African children with focal segmental glomerulosclerosis.
    Govender MA, Fabian J, Gottlich E, Levy C, Moonsamy G, Maher H, Winkler CA, Ramsay M.
    Commun Biol; 2019 Nov 01; 2():416. PubMed ID: 31754646
    [Abstract] [Full Text] [Related]

  • 3. APOL1 risk genotype in Europe: Data in patients with focal segmental glomerulosclerosis and after renal transplantation.
    Servais A, Gribouval O, Gaillard F, Antignac C.
    Nephrol Ther; 2019 Apr 01; 15 Suppl 1():S85-S89. PubMed ID: 30981401
    [Abstract] [Full Text] [Related]

  • 4. APOL1 in an ethnically diverse pediatric population with nephrotic syndrome: implications in focal segmental glomerulosclerosis and other diagnoses.
    Watanabe A, Guaragna MS, Belangero VMS, Casimiro FMS, Pesquero JB, de Santis Feltran L, Palma LMP, Varela P, de Menezes Neves PDM, Lerario AM, de Souza ML, de Mello MP, de Brito Lutaif ACG, Ferrari CR, Sampson MG, Onuchic LF, Nogueira PCK.
    Pediatr Nephrol; 2021 Aug 01; 36(8):2327-2336. PubMed ID: 33585978
    [Abstract] [Full Text] [Related]

  • 5. Causal and putative pathogenic mutations identified in 39% of children with primary steroid-resistant nephrotic syndrome in South Africa.
    Nandlal L, Winkler CA, Bhimma R, Cho S, Nelson GW, Haripershad S, Naicker T.
    Eur J Pediatr; 2022 Oct 01; 181(10):3595-3606. PubMed ID: 35920919
    [Abstract] [Full Text] [Related]

  • 6. APOL1-associated glomerular disease among African-American children: a collaboration of the Chronic Kidney Disease in Children (CKiD) and Nephrotic Syndrome Study Network (NEPTUNE) cohorts.
    Ng DK, Robertson CC, Woroniecki RP, Limou S, Gillies CE, Reidy KJ, Winkler CA, Hingorani S, Gibson KL, Hjorten R, Sethna CB, Kopp JB, Moxey-Mims M, Furth SL, Warady BA, Kretzler M, Sedor JR, Kaskel FJ, Sampson MG.
    Nephrol Dial Transplant; 2017 Jun 01; 32(6):983-990. PubMed ID: 27190333
    [Abstract] [Full Text] [Related]

  • 7. Identification of genetic causes for sporadic steroid-resistant nephrotic syndrome in adults.
    Gribouval O, Boyer O, Hummel A, Dantal J, Martinez F, Sberro-Soussan R, Etienne I, Chauveau D, Delahousse M, Lionet A, Allard J, Pouteil Noble C, Tête MJ, Heidet L, Antignac C, Servais A.
    Kidney Int; 2018 Nov 01; 94(5):1013-1022. PubMed ID: 30348286
    [Abstract] [Full Text] [Related]

  • 8. HLA-DQA1 and APOL1 as Risk Loci for Childhood-Onset Steroid-Sensitive and Steroid-Resistant Nephrotic Syndrome.
    Adeyemo A, Esezobor C, Solarin A, Abeyagunawardena A, Kari JA, El Desoky S, Greenbaum LA, Kamel M, Kallash M, Silva C, Young A, Hunley TE, de Jesus-Gonzalez N, Srivastava T, Gbadegesin R.
    Am J Kidney Dis; 2018 Mar 01; 71(3):399-406. PubMed ID: 29277510
    [Abstract] [Full Text] [Related]

  • 9. Dominant PAX2 mutations may cause steroid-resistant nephrotic syndrome and FSGS in children.
    Vivante A, Chacham OS, Shril S, Schreiber R, Mane SM, Pode-Shakked B, Soliman NA, Koneth I, Schiffer M, Anikster Y, Hildebrandt F.
    Pediatr Nephrol; 2019 Sep 01; 34(9):1607-1613. PubMed ID: 31001663
    [Abstract] [Full Text] [Related]

  • 10. APOL1 genotype-associated morphologic changes among patients with focal segmental glomerulosclerosis.
    Zee J, McNulty MT, Hodgin JB, Zhdanova O, Hingorani S, Jefferson JA, Gibson KL, Trachtman H, Fornoni A, Dell KM, Reich HN, Bagnasco S, Greenbaum LA, Lafayette RA, Gipson DS, Brown E, Kretzler M, Appel G, Sambandam KK, Tuttle KR, Chen D, Atkinson MA, Hogan MC, Kaskel FJ, Meyers KE, O'Toole J, Srivastava T, Sethna CB, Hladunewich MA, Lin JJ, Nast CC, Derebail VK, Patel J, Vento S, Holzman LB, Athavale AM, Adler SG, Lemley KV, Lieske JC, Hogan JJ, Gadegbeku CA, Fervenza FC, Wang CS, Matar RB, Singer P, Kopp JB, Barisoni L, Sampson MG.
    Pediatr Nephrol; 2021 Sep 01; 36(9):2747-2757. PubMed ID: 33646395
    [Abstract] [Full Text] [Related]

  • 11. Targeted next-generation sequencing in steroid-resistant nephrotic syndrome: mutations in multiple glomerular genes may influence disease severity.
    Bullich G, Trujillano D, Santín S, Ossowski S, Mendizábal S, Fraga G, Madrid Á, Ariceta G, Ballarín J, Torra R, Estivill X, Ars E.
    Eur J Hum Genet; 2015 Sep 01; 23(9):1192-9. PubMed ID: 25407002
    [Abstract] [Full Text] [Related]

  • 12. Clinical value of NPHS2 analysis in early- and adult-onset steroid-resistant nephrotic syndrome.
    Santín S, Tazón-Vega B, Silva I, Cobo MÁ, Giménez I, Ruíz P, García-Maset R, Ballarín J, Torra R, Ars E, FSGS Spanish Study Group.
    Clin J Am Soc Nephrol; 2011 Feb 01; 6(2):344-54. PubMed ID: 20947785
    [Abstract] [Full Text] [Related]

  • 13. An investigation of APOL1 risk genotypes and preterm birth in African American population cohorts.
    Robertson CC, Gillies CE, Putler RKB, Ng D, Reidy KJ, Crawford B, Sampson MG.
    Nephrol Dial Transplant; 2017 Dec 01; 32(12):2051-2058. PubMed ID: 27638911
    [Abstract] [Full Text] [Related]

  • 14. Precise clinicopathologic findings for application of genetic testing in pediatric kidney transplant recipients with focal segmental glomerulosclerosis/steroid-resistant nephrotic syndrome.
    Miura K, Kaneko N, Hashimoto T, Ishizuka K, Shirai Y, Hisano M, Chikamoto H, Akioka Y, Kanda S, Harita Y, Yamamoto T, Hattori M.
    Pediatr Nephrol; 2023 Feb 01; 38(2):417-429. PubMed ID: 35655039
    [Abstract] [Full Text] [Related]

  • 15. APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy.
    Kopp JB, Nelson GW, Sampath K, Johnson RC, Genovese G, An P, Friedman D, Briggs W, Dart R, Korbet S, Mokrzycki MH, Kimmel PL, Limou S, Ahuja TS, Berns JS, Fryc J, Simon EE, Smith MC, Trachtman H, Michel DM, Schelling JR, Vlahov D, Pollak M, Winkler CA.
    J Am Soc Nephrol; 2011 Nov 01; 22(11):2129-37. PubMed ID: 21997394
    [Abstract] [Full Text] [Related]

  • 16. Advances in molecular diagnosis and therapeutics in nephrotic syndrome and focal and segmental glomerulosclerosis.
    Sharif B, Barua M.
    Curr Opin Nephrol Hypertens; 2018 May 01; 27(3):194-200. PubMed ID: 29465426
    [Abstract] [Full Text] [Related]

  • 17. Clinical phenotype of APOL1 nephropathy in young relatives of patients with end-stage renal disease.
    Anyaegbu EI, Shaw AS, Hruska KA, Jain S.
    Pediatr Nephrol; 2015 Jun 01; 30(6):983-9. PubMed ID: 25530085
    [Abstract] [Full Text] [Related]

  • 18. Podocyte-associated gene mutation screening in a heterogeneous cohort of patients with sporadic focal segmental glomerulosclerosis.
    Laurin LP, Lu M, Mottl AK, Blyth ER, Poulton CJ, Weck KE.
    Nephrol Dial Transplant; 2014 Nov 01; 29(11):2062-9. PubMed ID: 24500309
    [Abstract] [Full Text] [Related]

  • 19. Sequencing rare and common APOL1 coding variants to determine kidney disease risk.
    Limou S, Nelson GW, Lecordier L, An P, O'hUigin CS, David VA, Binns-Roemer EA, Guiblet WM, Oleksyk TK, Pays E, Kopp JB, Winkler CA.
    Kidney Int; 2015 Oct 01; 88(4):754-63. PubMed ID: 25993319
    [Abstract] [Full Text] [Related]

  • 20. TRPC6 mutations in children with steroid-resistant nephrotic syndrome and atypical phenotype.
    Gigante M, Caridi G, Montemurno E, Soccio M, d'Apolito M, Cerullo G, Aucella F, Schirinzi A, Emma F, Massella L, Messina G, De Palo T, Ranieri E, Ghiggeri GM, Gesualdo L.
    Clin J Am Soc Nephrol; 2011 Jul 01; 6(7):1626-34. PubMed ID: 21734084
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.